Boehringer Ingelheim: payments to doctors
Reported under the Physician Payments Sunshine Act for Open Payments program years 2019–2025. Figures group every CMS reporting entity belonging to this corporate parent.
- Total reported
- $615.4M
- Providers paid
- 189,508
- Transactions
- 1,428,993
- Average per transaction
- $431
The average per transaction — $431 — is the number worth reading. A large total spread across hundreds of thousands of transactions is a company buying a great many modest meals at educational presentations. A large total across few transactions means consulting, speaking or royalty arrangements with a small number of physicians. The totals alone do not distinguish them.
Where the money went
| State | Total reported | Share |
|---|---|---|
| California | $77,131,434 | 12.5% |
| Texas | $65,003,041 | 10.6% |
| Florida | $64,550,130 | 10.5% |
| New York | $52,443,560 | 8.5% |
| North Carolina | $34,577,376 | 5.6% |
| Connecticut | $23,465,999 | 3.8% |
| Pennsylvania | $23,128,968 | 3.8% |
| Missouri | $19,844,824 | 3.2% |
| Massachusetts | $17,986,537 | 2.9% |
| Georgia | $16,802,270 | 2.7% |
| Tennessee | $16,602,015 | 2.7% |
| Illinois | $15,962,054 | 2.6% |
| Ohio | $13,744,090 | 2.2% |
| New Jersey | $13,180,374 | 2.1% |
| Michigan | $11,534,607 | 1.9% |
| Maryland | $11,338,708 | 1.8% |
| Washington | $11,134,923 | 1.8% |
| South Carolina | $10,090,720 | 1.6% |
| Arizona | $8,563,185 | 1.4% |
| Colorado | $8,535,527 | 1.4% |
| Minnesota | $8,482,914 | 1.4% |
| Louisiana | $8,189,685 | 1.3% |
| Oklahoma | $7,868,797 | 1.3% |
| Virginia | $7,727,551 | 1.3% |
| Kentucky | $6,652,851 | 1.1% |
| Alabama | $6,493,254 | 1.1% |
| Kansas | $6,279,457 | 1.0% |
| Mississippi | $5,631,998 | 0.9% |
| Utah | $5,142,273 | 0.8% |
| Indiana | $4,450,443 | 0.7% |
| Wisconsin | $4,368,197 | 0.7% |
| Oregon | $3,842,766 | 0.6% |
| Iowa | $3,505,267 | 0.6% |
| Nebraska | $3,411,008 | 0.6% |
| Puerto Rico | $3,282,424 | 0.5% |
| Nevada | $2,585,439 | 0.4% |
| District of Columbia | $2,350,937 | 0.4% |
| Rhode Island | $1,337,093 | 0.2% |
| Idaho | $1,302,623 | 0.2% |
| Arkansas | $981,801 | 0.2% |
| Hawaii | $789,082 | 0.1% |
| New Hampshire | $778,273 | 0.1% |
| New Mexico | $753,432 | 0.1% |
| North Dakota | $664,880 | 0.1% |
| Vermont | $578,754 | 0.1% |
| Montana | $564,618 | 0.1% |
| South Dakota | $553,946 | 0.1% |
| West Virginia | $528,271 | 0.1% |
| Delaware | $354,016 | 0.1% |
| Maine | $164,854 | 0.0% |
| Alaska | $158,309 | 0.0% |
| Wyoming | $20,788 | 0.0% |
| AP | $945 | 0.0% |
| Guam | $635 | 0.0% |
| AE | $460 | 0.0% |
| ZZ | $445 | 0.0% |
| XX | $425 | 0.0% |
| U.S. Virgin Islands | $290 | 0.0% |
Products named in Boehringer Ingelheim's payments
The drugs and devices most often named as the product a payment related to. A meal at a presentation about a product counts here, so this tracks what the company promotes as much as what it sells.
- JARDIANCE$52,023,768
- OFEV$14,178,864
- SPIRIVA RESPIMAT$3,503,911
- SPEVIGO$3,021,755
- STIOLTO RESPIMAT$2,923,329
- TRADJENTA$1,653,735
- SYNJARDY$1,611,380
- PRADAXA$999,218
- GILOTRIF$981,921
- GLYXAMBI$537,523
- SPIRIVA$430,518
- TRIJARDY XR$336,035
- CYLTEZO$295,177
- JASCAYD$130,792
- STIOLTO$116,040